ArticleFrontiers in psychiatry2022
Effect of the COVID-19 pandemic on the psychotropic drug consumption.
Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Patterns of psychotropic drug dispensation in Portugal amidst the COVID-19 pandemic and beyond.Scientific reports · 2026Article
- Trends in Sedative-Hypnotic Prescription Among Insomnia Patients: A Nationwide Cohort Study From 2010 to 2022 in Korea.Journal of Korean medical science · 2026Article
- Nationwide trends in psychiatric prescription practices for drugs with putative cognitive adverse effects in schizophrenia spectrum and bipolar disorders from 2013 to 2022.Journal of pharmaceutical policy and practice · 2026Article
- Spatiotemporal analysis of psychoactive drug consumption in Brazil during the COVID-19 pandemic.PloS one · 2026Article
- Fluctuations in dispensed out-patient psychotropic medication prescriptions during the COVID-19 pandemic in The Netherlands.BJPsych open · 2025Article
- Socioeconomic trends in anxiolytic, hypnotic, and sedative use among secondary school students in Spain from 2010 to 2021: a repeated cross-sectional design.International journal for equity in health · 2025Article
- Did the COVID-19 pandemic influence the use of psychotropic medications by university students and LGBTQIAPN+? A Brazilian multicenter study.Cadernos de saude publica · 2025Article
- The Use of Psychotropic Medications Before and During the COVID-19 Pandemic and Its Associated Factors.Journal of clinical medicine · 2024Article
- Antidepressant treatment initiation among children and adolescents with acute versus long COVID: a large retrospective cohort study.Child and adolescent psychiatry and mental health · 2024Article
- Prolonged increase in psychotropic drug use among young women following the COVID-19 pandemic: a French nationwide retrospective study.BMC medicine · 2024Observational
- Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic.Translational psychiatry · 2024Review
- Prescriptions of antidepressants and anxiolytics in France 2012-2022 and changes with the COVID-19 pandemic: interrupted time series analysis.BMJ mental health · 2024Article
- ADHD medicine consumption in Europe after COVID-19: catch-up or trend change?BMC psychiatry · 2024Article
- Benzodiazepine Interference with Fertility and Embryo Development: A Preliminary Survey in the Sea UrchinInternational journal of molecular sciences · 2024Article
- Sales trends of psychotropic drugs in the COVID-19 pandemic: A national database study in Brazil.Frontiers in pharmacology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Although the COVID-19 pandemic has had a negative impact on mental health, there is no comprehensive longitudinal study of the entire population of a country without selection bias. Objective: The objective of this study was to evaluate the prescription of psychotropic drugs during the COVID-19 pandemic, using data from the French national health data system (SNDS). Design settings and participants: Prescriptions for psychotropic drugs (antidepressants, anxiolytics, hypnotics, and antipsychotics) from 1 January 2015 to 30 September 2021 were collected from administrative data provided by the SNDS. This database includes more than 99% of the French population, i.e., 67 million people. The data were analyzed using an interrupted time series analysis (ITSA) model. Main outcomes and measures: Consumption of psychotropic drugs was aggregated in months and expressed in number of boxes per thousand inhabitants. Results: During the study period, more than 1.3 billion boxes of psychotropic medications were dispensed. Comparison of psychotropic drug dispensing before and after the pandemic showed a relative increase of 0.76 (95 CI 0.57 to 0.95, Conclusion and relevance: The COVID-19 pandemic had led to an increase in the consumption of psychotropic drugs, confirming the significant impact of the pandemic on the mental health of the general population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.